Get started
666

TOWA PHARMA. CO.

No trades
See on Supercharts
Overview
Financials News Ideas Forecast

6QC chart

Key stats

Market capitalization
‪820.45 M‬EUR
Dividend yield (indicated)
2.18%
Price to earnings Ratio (TTM)
11.6
Basic EPS (TTM)
1.5EUR
Net income
‪15.29 M‬EUR
Revenue
‪1.45 B‬EUR
Shares float
‪22.52 M‬
Beta (1Y)
0.20

About TOWA PHARMA. CO.

Sector
Health Technology
Headquarters
Kadoma
Employees (FY)
‪4.3 K‬
Website
towayakuhin.co.jp
Founded
1951
ISIN
JP3623150004
FIGI
BBG01103SBW9
Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its products include neurological and anti-allergic drugs, cardiovascular and respiratory drugs, gastrointestinal drugs, antibiotics and chemotherapeutic drugs, vitamins; hormone drugs, and other metabolic drugs. The company was founded in June 1951 and is headquartered in Osaka, Japan.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange TOWA PHARMA. CO. stocks are traded under the ticker 6QC.
TOWA PHARMA. CO. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
6QC earnings for the last quarter are 0.28 EUR per share, whereas the estimation was 0.15 EUR resulting in a 83.53% surprise. The estimated earnings for the next quarter are 0.18 EUR per share. See more details about TOWA PHARMA. CO. earnings.
TOWA PHARMA. CO. revenue for the last quarter amounts to ‪334.56 M‬ EUR despite the estimated figure of ‪332.89 M‬ EUR. In the next quarter revenue is expected to reach ‪360.23 M‬ EUR.
Yes, you can track TOWA PHARMA. CO. financials in yearly and quarterly reports right on TradingView.
6QC net income for the last quarter is ‪29.31 M‬ EUR, while the quarter before that showed ‪13.95 M‬ EUR of net income which accounts for 110.17% change. Track more TOWA PHARMA. CO. financial stats to get the full picture.
TOWA PHARMA. CO. dividend yield was 3.17% in 2022, and payout ratio reached 134.18%. The year before the numbers were 2.07% and 17.63% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 6QC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TOWA PHARMA. CO. stock right from TradingView charts — choose your broker and connect to your account.
6QC reached its all-time high on Oct 22, 2021 with the price of 26.5 EUR, and its all-time low was 10.9 EUR and was reached on Jul 11, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has ‪4.30 K‬ employees. See our rating of the largest employees — is TOWA PHARMA. CO. on this list?
We've gathered analysts' opinions on TOWA PHARMA. CO. future price: according to them, 6QC price has a max estimate of 30.79 EUR and a min estimate of 17.74 EUR. Read a more detailed TOWA PHARMA. CO. forecast: see what analysts think of TOWA PHARMA. CO. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TOWA PHARMA. CO. EBITDA is ‪215.61 M‬ EUR, and current EBITDA margin is 11.93%. See more stats in TOWA PHARMA. CO. financial statements.